The gap will close as it gets closer to June. Some holders selling will be due to opportunity costs and knowing it’s going no higher than 37, some would be selling as there is still risk the deal my fall through.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025